Date published: 2026-2-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

Piperlongumine (CAS 20069-09-4)

5.0(1)
Write a reviewAsk a question

Alternate Names:
Piplartine
Application:
Piperlongumine is a selective anticancer GSTP1 and Bcl-2 inhibitor
CAS Number:
20069-09-4
Purity:
≥97%
Molecular Weight:
317.34
Molecular Formula:
C17H19NO5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Piperlongumine is isolated from Piper longum, a cell-permeable inducer of cell-death in cancer cells. Shown to inhibit expression of Bcl-2 and enhance wild type p53 expression.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Piperlongumine, 10 mg

sc-364128
10 mg
$107.00

mel enviaran desde ALEMANIA?

Asked by: adonis
Thank you for the question. Customers located in Europe will be served by our European Support Office located in Heidelberg Germany. Please contact us to receive a sales quotation with estimated lead time. The product is currently in stock.
Answered by: Technical Support Europe
Date published: 2019-02-11

Dear SCBT Team,  Is product sc-364128 an exact isomer, or a racemate?  Thank you.

Asked by: Peter Zed
Thank you for your question. Please contact our Technical Service Department to request more detailed information about what is in stock currently for this chemical. Please call our European Support office toll-free at 00800 4573 8000, email europe@scbt.com, or contact us by live chat.
Answered by: Technical Support
Date published: 2018-09-25
  • y_2026, m_2, d_25, h_10CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_2
  • loc_en_US, sid_364128, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 138ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Wang et alWang et al. (PubMed ID 262466196) found that Piperlongumine induced autophagy and apoptosis in lung cancer cells via PI3K/Akt/mTOR pathway inhibition. -SCBT Publication Review
Date published: 2015-04-14
  • y_2026, m_2, d_25, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_364128, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT
Piperlongumine is rated 5.0 out of 5 by 1.
  • y_2026, m_2, d_25, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_364128, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 163ms
  • REVIEWS, PRODUCT